Showing results (261-270 of 351) with videos related to
Sort By:
Pageof 36
The Journal of Clinical Investigation|February 27, 2018
Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodesIkram Ullah, Govindasamy-Muralidharan Karthik, Amjad Alkodsi, et al.Nature Communications|October 20, 2019
CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samplesXiaolu Zhang, Silvano Garnerone, Michele Simonetti, et al.Breast Cancer Research : BCR|February 11, 2021
Molecular analyses of triple-negative breast cancer in the young and elderlyMattias Aine, Ceren Boyaci, Johan Hartman, et al.Virchows Archiv : an International Journal of Pathology|April 20, 2026
Level of estrogen receptor expression, histological grade, and computationally assessed stromal TILs on pre-treatment biopsies predict pathological complete response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancerDusan Rasic, Elisabeth Ida Specht Stovgaard, Anne Marie Bak Jylling, et al.Breast Cancer Research and Treatment|January 4, 2024
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trialYajing Zhu, Ioannis Zerdes, Alexios Matikas, et al.Tomography (Ann Arbor, Mich.)|June 18, 2020
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant TherapyAlex Anh-Tu Nguyen, Vignesh A Arasu, Fredrik Strand, et al.Journal of Breast Imaging|August 18, 2020
Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- PatientsVignesh A Arasu, Paul Kim, Wen Li, et al.Annals of Surgical Oncology|February 25, 2026
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 StudySherko Kuemmel, Peter A Fasching, Peter Schmid, et al.BMC Cancer|December 1, 2017
Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profilingGovindasamy-Muralidharan Karthik, Mattias Rantalainen, Gustav Stålhammar, et al.Nature Communications|July 18, 2025
Deciphering direct transcriptional effects of epigenetic compounds through large-scale new RNA profilingLeonard Hartmanis, Daniel Ramsköld, Gert-Jan Hendriks, et al.Pageof 36